Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Huang Y, He Y, Makarcyzk MJ, Lin H Frontiers in Bioengineering and Biotechnology (2021) This study demonstrated that FOXO4-DRI selectively removes senescent cells from human chondrocyte cultures expanded in vitro, providing direct evidence of the peptide's senolytic activity in human cells relevant to joint and cartilage aging
For example, Joe Rogan, a well-known commentator and fitness advocate, has spoken about BPC 157 peptide on his podcast, citing its impressive regenerative potential
Rheumatol Int 33:22772282
Semi-Solid Formulations Semi-solid formulations include nasal gels, thermo-responsive or pH-sensitive or ion-sensitive polymeric gels, and ointments
Always consult a licensed healthcare provider before beginning any new treatment.
Some peptides benefit from cycling periods of use followed by planned breaks